VentriPoint Diagnostics (TSE:VPT) has released an update.
Protect Your Portfolio Against Market Uncertainty
- Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
- Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
Ventripoint Diagnostics Ltd. has announced an extension of its non-brokered private placement of convertible debentures, aiming to raise funds for operational costs and growth. The debentures offer a conversion option into common shares and bear an interest rate of 10% annually. This initiative is part of Ventripoint’s strategy to bolster its sales, marketing, and overall business operations.
For further insights into TSE:VPT stock, check out TipRanks’ Stock Analysis page.